Literature DB >> 26555828

Risk Factors for Recurrence of Surgically Treated Conventional Spinal Schwannomas: Analysis of 169 Patients From a Multicenter International Database.

Michael G Fehlings1, Anick Nater, Juan J Zamorano, Lindsay A Tetreault, Peter P Varga, Ziya L Gokaslan, Stefano Boriani, Charles G Fisher, Laurence Rhines, Chetan Bettegowda, Norio Kawahara, Dean Chou.   

Abstract

STUDY
DESIGN: A retrospective analysis of 169 adult patients operated for a conventional spinal schwannoma from the AOSpine Multicenter Primary Spinal Tumors Database.
OBJECTIVE: The aim of this study is to identify risk factors for local recurrence of conventional spinal schwannoma in patients who had surgery. SUMMARY OF BACKGROUND DATA: Schwannomas account for up to 30% of all adult spinal tumors. Total resection is the gold standard for patients with sensory or motor deficits. Local recurrence is reported to be approximately 5% and usually occurs several years after surgery.
METHODS: Rates and time of local recurrence of spinal schwannoma were quantified. Predictive value of various clinical factors was assessed, including age, gender, tumor size, affected spinal segment, and type of surgery. Descriptive statistics and univariate regression analyses were performed.
RESULTS: Nine (5.32%) out the 169 patients in this study experienced local recurrence approximately 1.7 years postoperatively. Univariate analyses revealed that recurrence tended to occur more often in younger patients (39.33 ± 14.58 versus 47.01 ± 15.29 years) and in the lumbar segment (55.56%), although this did not reach significance [hazard ratio (HR) 0.96, P = 0.127; and P = 0.195, respectively]. Recurrence also arose in the cervical and sacral spine (22.22%, respectively) but not in the thoracic area. Tumors were significantly larger in patients with recurrence (6.97 ± 4.66  cm versus 3.81 ± 3.34  cm), with extent in the cranial caudal direction posing the greatest hazard (HR = 1.321, P = 0.002). The location of the tumor, whether epidural, intradural, or both (P = 0.246), was not significantly related to recurrence. Regarding surgical technique, over 4 times as many patients who underwent intralesional resection experienced a recurrence proportionally to patients who underwent en bloc resection (HR = 4.178, P = 0.033).
CONCLUSION: The pre-operative size of the conventional spinal schwannoma and intralesional resection are the main risk factors for local postoperative recurrence. LEVEL OF EVIDENCE: 3.

Entities:  

Mesh:

Year:  2016        PMID: 26555828      PMCID: PMC4769652          DOI: 10.1097/BRS.0000000000001232

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  28 in total

Review 1.  Neuropathology for the neuroradiologist: Antoni A and Antoni B tissue patterns.

Authors:  F J Wippold; M Lubner; R J Perrin; M Lämmle; A Perry
Journal:  AJNR Am J Neuroradiol       Date:  2007-09-24       Impact factor: 3.825

2.  En bloc resections for primary spinal tumors in 20 years of experience: effectiveness and safety.

Authors:  Luca Amendola; Michele Cappuccio; Federico De Iure; Stefano Bandiera; Alessandro Gasbarrini; Stefano Boriani
Journal:  Spine J       Date:  2014-02-20       Impact factor: 4.166

3.  Surgery of spinal nerve sheath tumors with special reference to neurofibromatosis.

Authors:  J Klekamp; M Samii
Journal:  Neurosurgery       Date:  1998-02       Impact factor: 4.654

4.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

5.  Long-term outcomes in primary spinal osteochondroma: a multicenter study of 27 patients.

Authors:  Daniel M Sciubba; Mohamed Macki; Mohamad Bydon; Niccole M Germscheid; Jean-Paul Wolinsky; Stefano Boriani; Chetan Bettegowda; Dean Chou; Alessandro Luzzati; Jeremy J Reynolds; Zsolt Szövérfi; Patti Zadnik; Laurence D Rhines; Ziya L Gokaslan; Charles G Fisher; Peter Paul Varga
Journal:  J Neurosurg Spine       Date:  2015-03-20

6.  Spinal schwannomas: a review of 42 cases.

Authors:  H Asahara; A Kawai; Y Harada; M Senda; H Inoue
Journal:  Acta Med Okayama       Date:  1996-02       Impact factor: 0.892

Review 7.  Adult primary intradural spinal cord tumors: a review.

Authors:  Marc C Chamberlain; Trent L Tredway
Journal:  Curr Neurol Neurosci Rep       Date:  2011-06       Impact factor: 5.081

8.  The surgical management of primary tumorsof the spine: initial results of an ongoing prospective cohort study.

Authors:  Charles G Fisher; Ory Keynan; Michael C Boyd; Marcel F Dvorak
Journal:  Spine (Phila Pa 1976)       Date:  2005-08-15       Impact factor: 3.468

9.  Microsurgical management of spinal schwannomas: evaluation of 128 cases.

Authors:  Sam Safavi-Abbasi; Mehmet Senoglu; Nicholas Theodore; Ryan K Workman; Alireza Gharabaghi; Iman Feiz-Erfan; Robert F Spetzler; Volker K H Sonntag
Journal:  J Neurosurg Spine       Date:  2008-07

Review 10.  Spinal neurinomas: retrospective analysis and long-term outcome of 179 consecutively operated cases and review of the literature.

Authors:  Piero Conti; Gastone Pansini; Homere Mouchaty; Christian Capuano; Renato Conti
Journal:  Surg Neurol       Date:  2004-01
View more
  14 in total

1.  Gene therapy with apoptosis-associated speck-like protein, a newly described schwannoma tumor suppressor, inhibits schwannoma growth in vivo.

Authors:  Sherif G Ahmed; Ahmed Abdelnabi; Casey A Maguire; Mohamed Doha; Jessica E Sagers; Rebecca M Lewis; Alona Muzikansky; Marco Giovannini; Anat Stemmer-Rachamimov; Konstantina M Stankovic; Giulia Fulci; Gary J Brenner
Journal:  Neuro Oncol       Date:  2019-07-11       Impact factor: 12.300

2.  Intratumoral injection of schwannoma with attenuated Salmonella typhimurium induces antitumor immunity and controls tumor growth.

Authors:  Sherif G Ahmed; Giulia Oliva; Manlin Shao; Xinhui Wang; John J Mekalanos; Gary J Brenner
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-08       Impact factor: 12.779

3.  Oversized primary intrapulmonary schwannoma: A case report and a review of the literature.

Authors:  Sara Zarei; Alina Popa; Bahman Moghadam; Archana Reddy; Ahmed Mahmoud
Journal:  Surg Neurol Int       Date:  2020-08-08

Review 4.  Intraosseous schwannoma of the mobile spine: a report of twenty cases.

Authors:  Yong Qiang Wang; Jin Xin Hu; Shao Min Yang; Liang Jiang; Xiao Guang Liu; Hui Shu Yuan; Feng Wei; Zhong Jun Liu
Journal:  Eur Spine J       Date:  2018-09-18       Impact factor: 3.134

5.  Clinical features and surgical treatment of sacral schwannomas.

Authors:  Weibo Pan; Zhan Wang; Nong Lin; Xin Huang; Meng Liu; Xiaobo Yan; Zhaoming Ye
Journal:  Oncotarget       Date:  2017-06-06

6.  Schwannoma of the lumbar spine, presenting with pain of the knee, like an osteoid osteoma, in a 10-year-old girl.

Authors:  Nikolaos Laliotis; Chrysanthos Chrysanthou; Nikolaos Baskinis; Panagiotis Konstandinidis; Lambrini Giannakopoulou; Katerina Zarampouka
Journal:  Clin Case Rep       Date:  2020-11-11

7.  A rare case of intramedullary schwannoma at conus medullaris: A case report with review of literature.

Authors:  Rahul Varshney; Pranjal Bharadwaj; Ajay Choudhary; Purnima Paliwal; Kaviraj Kaushik
Journal:  Surg Neurol Int       Date:  2020-12-22

8.  Large lumbosacral schwannoma in a young female- a case report from Afghanistan.

Authors:  Sayed Hanif Monawary; Shafi Ullah Zahid; Kalimullah Wardak; Kiran Shafiq Khan; Irfan Ullah; Zohaib Yousaf
Journal:  Ann Med Surg (Lond)       Date:  2021-10-30

9.  Spinal Nerves Schwannomas: Experience on 367 Cases-Historic Overview on How Clinical, Radiological, and Surgical Practices Have Changed over a Course of 60 Years.

Authors:  Jacopo Lenzi; Giulio Anichini; Alessandro Landi; Alfonso Piciocchi; Emiliano Passacantilli; Francesca Pedace; Roberto Delfini; Antonio Santoro
Journal:  Neurol Res Int       Date:  2017-09-18

10.  Schwannoma Gene Therapy via Adeno-Associated Viral Vector Delivery of Apoptosis-Associated Speck-like Protein Containing CARD (ASC): Preclinical Efficacy and Safety.

Authors:  Sherif G Ahmed; Casey A Maguire; Shiliang Alice Cao; Gary J Brenner
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.